Back

State-of-the-art lecture in lipid lowering therapy and the atheroma .

26 August 2022 (16:30 - 16:50)
Organised by:
Congress Presentation Part of: Lipid-lowering therapy and the atheroma Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

2 More presentations in this session

Presentation thumbnail
Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: Further insights from the ODYSSEY OUTCOMES trial
Doctor S. Goodman (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: Insights from the PACMAN-AMI randomized trial
Doctor K. Koskinas (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering therapy and the atheroma
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of intensive low-density lipoprotein cholesterol lowering therapy on intermediate stenosis in non-culprit vessels of acute coronary syndrome
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources